Toripalimab offers new possibilities for treating nasopharyngeal carcinoma. Join us TODAY at 2 PM EST to hear from Dr. Jong Chul Park of Massachusetts General Hospital as he shares insight?into the clinical aspects and management strategies for this treatment. Follow the link to join:?https://lnkd.in/eyeGJdGW
NCODA的动态
最相关的动态
-
??New study explores how FDG PET-CT influences treatment decisions for locally advanced carcinoma cervix, reporting on clinical outcomes & PROMs ??PET-CT led to treatment plan changes in 13% of cases, positively impacting long-term survival & quality of life https://ow.ly/7W2X50SkrPY
-
When treating unresectable hepatocellular carcinoma (uHCC), oncologists do everything in their power to maximize overall survival (OS). In addition, other measures like minimizing BLEEDING RISK also need to be effectively addressed. Depending on therapy, patients may require prior screening for varices. This could potentially delay treatment initiation. Learn more at https://lnkd.in/eDkzXC29. #ExploreHCC #EveryMeasureMatters
-
Prostate cancer risk assessment is opportunistic and mainly focused on family history, PSA levels and physical examination. The results generally imply a high rate of overdiagnosis and overtreatment. Carrying out #myHealthScore ?? allows the integration of polygenic risk into medical checkups, providing more precise and complete information on patient risk. ?? https://hubs.ly/Q02gp81L0
-
-
It was great pleasure to meet and talk to Dr. Irene Bargellini during CIRSE in Lisbon. Listen, what she says about Liver cancer and novel developments in management of the patients with #HCC. #hepatocellularcarcinoma #girisimselradyoloji #tgrd
[Liver awareness month] ?? What symptoms should alert patients to the possibility of developing an HCC? Early detection can save lives. Watch this video with Irene Bargellini, Interventional Radiologist from University of Pisa, to learn about the key signs to look out for in hepatocellular carcinoma (HCC). #LiverHealth #HCCRisk #LiverCancer
-
In a study involving over 1,000 patients, NETest 2.0 achieved 94% sensitivity in detecting neuroendocrine tumors. This high accuracy ensures that patients get the right diagnosis and treatment plan from the start. Explore how NETest 2.0 is leading the way in NET diagnostics. We are on a mission to detect early. Learn how more accurate results are guiding healthcare decisions > https://hubs.la/Q02NwSxQ0 #NETDiagnosisMadeSimple #EarlyNETDetectionMatters #NeuroendocrineTumorAwareness #KnowYourNETStatus #NETDetectionBreakthrough #FasterNETDetection #PrecisionNETDiagnostics #NETPrognosticPower #DetectNETsBetter #NETSurvivorship #wrenlabs #cancerdetection #beatcancer #fightcancer
-
-
In 2015 new ATA guidelines offered thyroid lobectomy as a choice for treatment in patients with low risk thyroid cancers. How often do these folks need re-operation? Dr. Toni Beninato and her team at Rutgers Robert Wood Johnson Medical School answer this question in a new article in #ThyroidJournal. https://ow.ly/Kypa50T8Gnq
-
-
Chair of Breast Cancer Surgery @ The London Breast Institute | Consultant Oncoplastic Breast Surgeon
Aligned with clinical practice observations: Patients with invasive lobular cancinoma (ILC) survive better in early years but worse in later years compared to patients with invasive ductal carcinoma (IDC). https://lnkd.in/dV8ydn64
-
DIBS (Daily Information Bulletin Service) on Carcinoma Pancreas Swipe to read more Follow @nextillo_ for more informational content like this! #medicalmemes #medicalinfo #medicalstudent #medicalinformation #fmgequestions #fmgepreparation #neetpg
-
-
At ACMA, we are committed to the transformative role of education in improving health and wellness. In honor of UV Safety Month this July, we will be sharing important tips to help you protect yourself from skin cancer and raise awareness! Basal cell carcinoma (BCC) and squamous cell carcinoma (SCC) are the most common non-melanoma types, while melanoma poses the highest mortality risk due to its potential to spread. Increased UV exposure, aging populations, and improved detection methods contribute to rising incidence rates. Stay informed and spread awareness! #SkinCancerAwareness #Melanoma #BasalCellCarcinoma #SquamousCellCarcinoma #HealthAwareness #ACMA #health #medicalaffairs #medicalnews
-
-
Vice President | Immuno-Oncology | Cell Therapy | Hematology | Drug Development | Bristol-Myers Squibb | Physician
New treatment options that directly address the underlying condition are needed for autoimmune diseases. As co-chair of Bristol Myers Squibb’s recently formed ACTioN, I am thrilled to connect with this group of leaders in #CARTcelltheray and #immunology at #EULAR2024 to discuss our collective goal of discovering how cell therapy can transform the treatment landscape. Visit our ACTioN page on BMS.com to learn more about the potential of cell therapy in immunology: https://rb.gy/92nksr #BMS_Employee
Inspired by the potential of #CARTcelltherapy to advance the care of patients living with serious autoimmune diseases, we are building a network of experts to join forces and, together, reimagine the future of treatment for these patients. Collaboration is critical to make new discoveries and accelerate innovative treatments for patients. This year at #EULAR2024, we are convening a group of ACTioN members to help us chart a path to unlock the potential of cell therapy for the treatment of certain serious autoimmune diseases with urgent unmet needs. Learn more about how we plan to take action with ACTioN: https://bit.ly/3Xl0Yex
-
